ClinicalTrials.gg
DrugRead study by study

Tiragolumab clinical trials

Also written MTIG7192A and RO7092284.

studies test it
65
open now
7
in phase 3
10
first study started
2016
ClinicalTrials.gov finds 67 studies for Tiragolumab. How that becomes 65 hereChecked on ClinicalTrials.gov

Every study that search finds has been read, to see whether and how it gives Tiragolumab. Its counts are asked again every night. How drug pages count

  1. 67Found by its intervention search · See all 67 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 63 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. −1
    Mention it without giving it — earlier treatment, a protocol code, a title naming another drug
  3. +1Give it under a name that search misses: a biosimilar’s code or a misspelling
  4. 67Give Tiragolumab to participants
  5. −2Give it beside what is tested
  6. 65Test it: the count on this site

Get an email when these change. Save the Tiragolumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tiragolumab
58
MTIG7192A; RO7092284
3
Anti-TIGIT
2

Development codes

MTIG7192A
14
RO7092284
9
RG6058
5

In one entry with another drug

Given together, or one or the other

Tiragolumab and Atezolizumab
2

Studies by the year they started

65 studies that test it; most in 2023 (16)

Studies that test Tiragolumab, by start year
YearStudies
20161
20173
20182
20195
202010
20219
20227
202316
20244
20258

Who runs them

Industry 35 · Other 30

Hoffmann-La Roche (31) · M.D. Anderson Cancer Center (7) · National Cancer Institute (NCI) (4) · Genentech, Inc. (4) · Alliance Foundation Trials, LLC. (2) · Omico (1) · Georgetown University (1) · Alain Algazi (1)

Often tested with

Tested in the same studies.

Atezolizumab (13) · Bevacizumab (6) · Tobemstomig (5) · Cobimetinib (4) · Inavolisib (4) · Ipatasertib (4) · Tocilizumab (3) · Gemcitabine (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8

Studies that test Tiragolumab.

Studies

Open first, then newest update. How each study uses Tiragolumab has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 65

See all 65 studies that test Tiragolumab →

Tested on its own · 1 — no other medicine in its arm
Tested with established drugs · 36 — they are given beside it

Showing 20 of 36. See all 36 →

Tested in a combination · 28 — another drug in the study is under test too

Showing 20 of 28. See all 28 →

Beside an established treatment under test · 1 — an approved drug, surgery or radiation is what the study tests

Codes

What other systems call Tiragolumab · ClinicalTrials.gg INT002091

  • MeSH (NLM) C000730814TiragolumabOne source ClinicalTrials.gov
  • UNII (FDA) 6XG22YQM2ZTIRAGOLUMABOne source FDA
  • NCI Thesaurus C131291TiragolumabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion